Skip to main content

Table 2 Office and ambulatory blood pressure measurements at the end of intervention

From: The impact of propranolol on nitric oxide and total antioxidant capacity in patients with resistant hypertension—evidence from the APPROPRIATE trial

Blood PressurePropranolol (mmHg)Placebo (mmHg)P value
Office Blood pressure at end of intervention
 SBP (Systolic BP)130.0 ± 13.2139.93 ± 14.170.046
 DBP (Diastolic BP)77.8 (± 9.7)82.66 ± 8.580.142
Mean reduction in office SBP29.7 ± 13.018.07 ± 14.630.021
Mean reduction in office DBP12.4 ± 12.86.33 ± 16.590.242
Mean ambulatory BP at the end of intervention
 SBP (Systolic BP)137.3 ± 12.6149.2 ± 12.50.080
 DBP (Diastolic BP)79.4 ± 5.584.1 ± 8.40.050
Mean reduction in ambulatory SBP11.2 ± 14.74.1 ± 13.30.138
Mean reduction ambulatory DBP5.4 ± 6.1− 3.5 ± 15.60.031